AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on ...

Alliance News 30 November, 2023 | 11:04AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.




Ashtead Technology Holdings PLC, up 20% at 582.00 pence, 12-month range 281.00p-594.00p. The subsea equipment rental, serving the offshore energy sector, says it now expects 2023 results to be "comfortably ahead of its previous expectations". It also announces a GBP53.5 million deal to acquire ACE Winches, from that firm's founders Alfie and Valerie Cheyne. ACE offers lifting, pulling and deployment services, and will sit nicely with "Ashtead Technology's existing equipment and services portfolio", it says.




Proteome Sciences PLC, down 25% at 4.54p, 12-month range 3.15p-8.79p. The protein-focused drug development services provider cuts its revenue outlook for 2023 amid delays to projects. It expects its top line to shrink from 2022's GBP7.8 million. "As reported by many other life science technology providers, the company has experienced delays to projects, many of which have been postponed to 2024. The healthcare industry has faced a very challenging market environment this year, especially in the second half of the year," Proteome Sciences explains. Proteome adds that reduced revenue combined with its commitment to invest in a US lab, means its now expects to post a net loss for 2023. In 2022, the company posted a profit after tax of GBP1.3 million. Proteome says it expects its US laboratory to be operational in the coming weeks and is lining up first customer projects for this laboratory.


Totally PLC, down 16% at 4.85p, 12-month range 4.80p-38.00p. A poor week for the stock continues and it looks likely to suffer a fourth-successive share price decline. On Tuesday, the healthcare services provider in UK and Ireland reported that it swung to a pretax loss of GBP1.9 million in the first half ended September 30, from a profit of GBP1.0 million the year prior. Revenue fell 21% to GBP55.8 million during the period, from GBP70.3 million a year ago, Totally said. The firm blamed a "crisis" faced by the UK NHS for the lower revenue, given the loss of its North West London contracts. Shares have fallen 48% so far this week and it hit this 12-month low on Thursday.


By Eric Cunha, Alliance News news editor

Comments and questions to

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Totally PLC 5.75 GBX 0.00 -
Proteome Sciences PLC 4.16 GBX -2.35 -
Ashtead Technology Holdings PLC Ordinary Shares 702.00 GBX 0.29 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures